Article

B+L launches peroxide-based lens solution

Bausch + Lomb has introduced a new peroxide cleaning and disinfecting solution, PeroxiClear 3%.

 

Bridgewater, NJ-Bausch + Lomb has introduced a new peroxide cleaning and disinfecting solution, PeroxiClear 3%.

The new solution offers an alternative peroxide-based product, and has been proven to keep contact lenses cleaner and moister for longer, according to the company.

“We’ve been hearing from many doctors that there’s been an increasing need to address their patients’ contact lens discomfort,” said Josephy Barr, OD, MS, FAAP, vice president, medical affairs, pharmaceuticals and vision care, Bausch  + Lomb. “(The company) is proud to now provide an alternative option and innovation with (this solution).

“Bausch + Lomb’s mission has always been to help patients see better to live better, and with the introduction of (this) cleaning and disinfecting solution, we can now offer them the most advanced peroxide-based lens solution on the market today,” Barr continued.

The solution will be available in major retailers starting in April and May, including Target, Rite-Aid, K-Mart, Walmart, Walgreens, and CVS. It will be available at most retailers nationwide by June.

The solution was also presented during SECO last week, and will again be shown during Vision Expo East next week in New York City.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.